Drug use by demented and non-demented elderly people

Age and Ageing

Volumn 26, Issue 5, 1997, Pages 383-391

  Wills, Phillipa ^a   Claesson, Cecilia B ^b,c   Fratiglioni, Laura ^a,d   Fastbom, Johan ^a   Thorslund, Mats ^e   Winblad, Bengt ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c Natl Corp of Swedish Pharmacies   (Sweden)

^d UNIVERSITY OF FLORENCE   (Italy)

^e STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Alzheimer's disease; Dementia; Drug utilization; Elderly; Institutional care; Nursing home; Opioids; Psychotropics

Indexed keywords

ANALGESIC AGENT; LAXATIVE; NEUROLEPTIC AGENT; OPIATE; PSYCHOTROPIC AGENT;

AGED; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DATA ANALYSIS; DEMENTIA; DISEASE SEVERITY; DRUG UTILIZATION; FEMALE; HOME CARE; HUMAN; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SWEDEN; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; DEMENTIA; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INSTITUTIONALIZATION; MALE; PSYCHOTROPIC DRUGS; SEX FACTORS; SWEDEN;

EID: 0030817022     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/26.5.383     Document Type: Article

References (41)

1. Fratiglioni L, Grut M, Forsell Y et al. Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex and education. Neurology 1991; 41: 1886-92.
2. Sandman P-O, Adolfsson R, Norberg A et al. Long-term care of the elderly. A descriptive study of 3600 institutionalized patients in the county of Västerbotten, Sweden. Compr Gerontol [A] 1988; 2: 120-33.
3. Skoog I, Nilsson L, Landahl S et al. Mental disorders and the use of psychotropic drugs in an 85-year-old urban population. Int Psychogeriatr 1993; 5: 33-48.
4. Katzman R, Hill R, Yu ESH et al. The malignancy of dementia. Predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. Arch Neurol 1994; 51: 1220-5.
5. Ames D, Tuckwell V. Psychopharmacology in the 1990s. What does the future hold for the aged patient? Drugs Aging 1991; 1: 339-44.
6. Olanders S. Neuroleptics in geriatrics. In: Strandberg K, Beermann B, Lönnerholm G, eds. Workshop: treatment with neuroleptics. Uppsala, Sweden: National Board of Health and Welfare Drug Information Committee, 1990; 1: 113-32.
7. Buckholtz NS. Alzheimer's disease drug development and testing at the National Institute on Aging. Psychopharmacol Bull 1994; 30: 15-7.
8. Semla TP, Cohen D, Paveza G et al. Drug use patterns of persons with Alzheimer's disease and related disorders living in the community. J Am Geriatr Soc 1993; 41: 408-13.
9. Landahl S. Drug treatment in 70-82-year-old persons. A longitudinal study. Acta Med Scand 1987; 221: 179-84.
10. Peisah C, Brodaty H. Practical guidelines for the treatment of behavioural complications of dementia. Med J Aust 1994; 161: 558-63.
11. Frank EM. Effect of Alzheimer's disease on communication function. J SC Med Assoc 1994; 90: 417-23.
12. Aronow WS. Digoxin or angiotensin converting enzyme inhibitors for congestive heart failure in geriatric patients. Which is the preferred treatment? Drugs Aging 1991; 1: 98-103.
13. Nolan L, O'Malley K. Prescribing for the elderly. Part 1: sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988; 36: 142-9.
14. Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital. J Am Geriatr Soc 1989; 37: 323-6.
15. Wolf-Klein GP, Silverstone FA, Brod MS et al. Are Alzheimer's patients healthier? J Am Geriatr Soc 1988; 36: 219-24.
16. Renner EA, Engle VF, Graney MJ. Prevalence and predictors of regularly scheduled prescription medications of newly admitted nursing home residents. J Am Geriatr Soc 1992; 40: 232-6.
17. Andersson M. Drugs prescribed for elderly patients in nursing homes or under medical home care. Compr Gerontol 1989; 3 (suppls A+B): 8-15.
18. Travis SS, Moore SR. Nursing and medical care of primary dementia patients in a community hospital setting. Appl Nurs Res 1991; 4: 14-8.
19. Lacro JP, Jeste DV. Physical comorbidity and polypharmacy in older psychiatric patients. Biol Psychiatry 1994; 36: 146-52.
20. Fratiglioni L, Viitanen M, Bäckman L et al. Occurrence of dementia in advanced age: the study design of the Kungsholmen project. Neuroepidemiology 1992; 11 (suppl. 1): 29-36.
21. Grut M, Fratiglioni L, Viitanen M et al. Accuracy of the Mini-Mental Status Examination as a screening test for dementia in a Swedish elderly population. Acta Neurol Scand 1993; 87: 312-7.
22. Forsell Y, Fratiglioni L, Grut M et al. Clinical staging of dementia in a population survey: comparison of DSM-III-R and the Washington University Clinical Dementia Rating Scale. Acta Psychiatr Scand 1992; 86: 49-54.
23. World Health Organisation. Guidelines for ATC (Anatomical Therapeutic Classification). Oslo: World Health Organisation Collaborating Centre for Drug Statistics Methodology, 1993.
24. Robinson D, Bucci J. Fenn H. Pain assessment in the Alzheimer's patient. J Am Geriatr Soc 1995; 43: 318-9.
25. SPSS for windows. Release 6.0. Chicago, IL: SPSS Inc., 1993.
26. Stata Release 3.1. College Station, TX: Stata Corp., 1993.
27. Thorslund M et al. Drug use in an elderly population -the role of the organizational environment. Submitted.
28. Hansen EH. How widely do women and men differ in their use of psychotropic drugs? J Soc Adm Pharm 1989; 6: 165-83.
29. van der Waals FW, Mohrs J, Foets M. Sex differences among recipients of benzodiazepines in Dutch general practice. Br Med J 1993; 307: 363-6.
30. Fastbom J, Claesson CB, Cornelius C et al. The use of medicines with anticholinergic effects in older people: a population study in an urban area of Sweden. J Am Geriatr Soc 1995; 43: 1135-40.
31. Semla TP, Palla K, Poddig B et al. Effect of the Omnibus Reconciliation Act 1987 on antipsychotic prescribing in nursing home residents. J Am Geriatr Soc 1994; 42: 648-52.
32. Sandman P-O, Adolfsson R, Eriksson S. Prescription of psychopharmaceutical drugs to the elderly in institutions in Sweden. In: Strandberg K, Beermann B, Lönnerholm G, eds. Workshop: treatment with neuroleptics. Uppsala, Sweden: National Board of Health and Welfare Drug Information Committee, 1990; 1: 85-93.
33. Yeager BF, Farnett LE, Ruzicka SA. Management of the behavioral manifestations of dementia. Arch Intern Med 1995; 155: 250-60.
34. Ray WA, Taylor JA, Meador KG et al. Reducing antipsychotic drug use in nursing homes. Arch Intern Med 1993; 153: 713-21.
35. Sloane PD, Mathew LJ, Scarborough M et al. Physical and pharmacologic restraint of nursing home patients with dementia. Impact of specialized units. JAMA 1991; 265: 1278-82.
36. Nordenstam I, Wennberg M, Kristoferson K. Svensk Läkemedels-Statistik 1993. Stockholm: Apoteksbolaget, 1994; 199-249.
37. Ekman S-L, Robins Wahlin T-B, Viitanen M et al. Preconditions for communication in the care of bilingual demented persons. Int Psychogeriatr 1994; 6: 105-20.
38. Schor JD, Levkoff SE, Lipsitz LA et al. Risk factors for delirium in hospitalized elderly. JAMA 1992; 267: 827-31.
39. Cornelius C, Fastbom J, Claesson CB et al. Self-reported symptoms in the elderly. Prevalence and association with drug use. Clin Drug Inv 1997; 13: 105-17.
40. Basun H, Fratiglioni L, Winblad B. Cobalamin levels are not reduced in Alzheimer's disease: Results from a population study. J Am Geriatr Soc 1994; 42: 132-6.
41. 12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx longitudinal aging study. J Am Geriatr Soc 1994; 42: 933-6.